Skip to content

Could leronlimab, a CCR5 blocker, be used to facilitate stem-cell transplant cures of HIV?

Illustration of HIV cells in pink and purple.

Returning to HIV care does not erase the effects of treatment interruption, studies show

Sanele Mbeje at AIDS 2026. He is standing at a lectern, behind a laptop, talking into a microphone.

Enhanced access to diagnostic screening improves care for advanced HIV

Dr John Fly Phiri at AIDS 2026. He is standing at a lectern, talking into a microphone.

Alternative first-line HIV regimen limits excess weight gain

Dr Joana Woods at AIDS 2026. She is talking into a microphone with a laptop screen in front of her.

New US HIV agreements leave civil society and key populations on the sidelines

Activists protesting at AIDS 2026. They are holding up placards about 'Trump's cuts'.

Fiji’s perfect HIV storm

Dr Jason Mitchell at AIDS 2026. He is sitting with three other people (to his left) at a press conference and is talking into a microphone.

Two more people cured of HIV after stem cell transplants, offering more clues to long-term remission

Dr Wissam El Atrouni and Dr Carina Elsner at AIDS 2026. Wissam is on the left talking into a microphone.

Over 40% of Ugandan mothers whose infants acquired HIV were only diagnosed while breastfeeding

Linda Nabitaka at AIDS 2026. She is sitting down, looking off to her right.

PEPFAR cuts close key population services and accelerate decline in children's HIV treatment

Elise Lankiewicz at AIDS 2026. Elise is standing behind a microphone, with a screen behind her.